79% want to quit or move to reduced risk products.
We design products to help.
Over 3 million Australians smoke,
Clinical Research Study
New research published in the Annals of Internal Medicine shows that vaping products are significantly more effective than nicotine replacement therapy (NRT) for helping smokers from disadvantaged backgrounds quit. The trial demonstrated a 28.4% quit rate for vaping compared to 9.6% for NRT after six months.
Information on nicotine vaping products (NVPs)
In 2019 we became the first company to launch a dedicated therapeutic vaping product range, through pharmacies in Australasia. Since 2020 we have been working with health care professionals throughout Australia. We have extensive knowledge in the field of therapeutic nicotine vaping products (NVPs) and our experienced team is here to help.
Please contact us to learn more about the category.
The myriad difference
Locally supplied and fully insured
Myriad is the only Nicotine Vaping Product (NVP) manufacturer with Australian-issued product liability insurance.
Ask us to prove it – we’ll provide our certificate of currency.
Domestic pharmacy distribution
Myriad products are available via Symbion, CH2, Anspec, and our direct wholesale portal, ensuring convenient nationwide access for all pharmacies.
Compliant product
All Myriad products comply with current TGA regulations, including the updated product and packaging standards.
Ask us to prove it – we’ll gladly provide our product transition guide.
